Efflux reprogramming promotes Staphylococcus aureus persistence with Pseudomonas aeruginosa in cystic fibrosis
- 1Infectious Diseases Division and Medical Services, Massachusetts General Hospital, Boston, Massachusetts, USA
- 2Department of Pediatrics, Massachusetts General Hospital, Boston, Massachusetts, USA
- 3Harvard Medical School, Boston, Massachusetts, USA
Abstract
Staphylococcus aureus persists in cystic fibrosis (CF) airways despite in vitro antibiotic susceptibility, suggesting that efflux reprogramming driven by environmental and polymicrobial interactions with Pseudomonas aeruginosa promotes survival in this setting. In this study, we investigated how CF-like conditions and co-infection with P. aeruginosa influence S. aureus physiology and antimicrobial response. Using artificial sputum medium (ASM) and co-culture models, we found that ASM induced a selective transcriptional response characterized by upregulation of the multidrug efflux pump tet38, while other pumps remained minimally expressed. In the presence of P. aeruginosa, S. aureus maintained tet38 expression but additionally induced norB, indicating a redistribution of efflux activity under polymicrobial stress. P. aeruginosa metabolites, including quinolines and phenazines, contributed to this response, and deletion of tet38 or norB significantly reduced S. aureus fitness in ASM and co-culture conditions. Analysis of S. aureus clinical isolates from people with CF revealed a similar hierarchy, with Tet38 and NorB as the predominant efflux pumps, particularly in S. aureus isolates co-recovered with P. aeruginosa. Despite exhibiting only low-level increases in MICs, these isolates demonstrated enhanced survival in ASM. Notably, S. aureus isolates paired with clinical P. aeruginosa strains showed improved survival compared with survival when paired with a P. aeruginosa reference strain, consistent with adaptation toward coexistence. Together, these findings demonstrate that CF-like environmental conditions and polymicrobial interactions drive selective reprogramming of efflux pumps that promote S. aureus persistence without conferring high-level resistance, highlighting a mechanism of antibiotic tolerance not captured by standard susceptibility testing.
Related
- Antibiofilm and Quorum-sensing Agents Against Pseudomonas aeruginosa and Staphylococcus aureus: a Systematic Review of Preclinical Studies, 2022-2026
- Investigation of Carbapenemase Resistance Genes and Plasmid-Mediated Quinolone Resistance Genes in Ceftolozane/Tazobactam-Resistant Enterobacterales and Pseudomonas aeruginosa Isolates
- Collateral effects of bacteriophage resistance on antibiotic sensitivity in Pseudomonas aeruginosa
- Structure of the cupin protein GloB from Pseudomonas aeruginosa at 1.48 Å resolution
- Phenotypic Characterization of Multidrug-Resistant Pseudomonas aeruginosa Isolated From Patients With Ventilator-Associated Pneumonia: Insights Into Resistance Mechanisms and Biofilm Formation
BibTeX
@article{truongbolduc2026efflux,
title = {{Efflux reprogramming promotes Staphylococcus aureus persistence with Pseudomonas aeruginosa in cystic fibrosis}},
author = {Q. C. Truong-Bolduc and Y. Wang and B. Alvarez-Carcamo and C. Steifman and B. G. Lawton and L. M. Yonker and B. P. Hurley and L. G. Rahme and D. C. Hooper},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2026},
month = nov,
doi = {10.1128/aac.01070-26},
url = {https://doi.org/10.1128/aac.01070-26},
note = {CC BY},
}
RIS
TY - JOUR
TI - Efflux reprogramming promotes Staphylococcus aureus persistence with Pseudomonas aeruginosa in cystic fibrosis
AU - Q. C. Truong-Bolduc
AU - Y. Wang
AU - B. Alvarez-Carcamo
AU - C. Steifman
AU - B. G. Lawton
AU - L. M. Yonker
AU - B. P. Hurley
AU - L. G. Rahme
AU - D. C. Hooper
PY - 2026
DA - 2026/11/04
JO - Antimicrobial Agents and Chemotherapy
DO - 10.1128/aac.01070-26
UR - https://doi.org/10.1128/aac.01070-26
AB - Staphylococcus aureus persists in cystic fibrosis (CF) airways despite in vitro antibiotic susceptibility, suggesting that efflux reprogramming driven by environmental and polymicrobial interactions with Pseudomonas aeruginosa promotes survival in this setting. In this study, we investigated how CF-like conditions and co-infection with P. aeruginosa influence S. aureus physiology and antimicrobial response. Using artificial sputum medium (ASM) and co-culture models, we found that ASM induced a selective transcriptional response characterized by upregulation of the multidrug efflux pump tet38, while other pumps remained minimally expressed. In the presence of P. aeruginosa, S. aureus maintained tet38 expression but additionally induced norB, indicating a redistribution of efflux activity under polymicrobial stress. P. aeruginosa metabolites, including quinolines and phenazines, contributed to this response, and deletion of tet38 or norB significantly reduced S. aureus fitness in ASM and co-culture conditions. Analysis of S. aureus clinical isolates from people with CF revealed a similar hierarchy, with Tet38 and NorB as the predominant efflux pumps, particularly in S. aureus isolates co-recovered with P. aeruginosa. Despite exhibiting only low-level increases in MICs, these isolates demonstrated enhanced survival in ASM. Notably, S. aureus isolates paired with clinical P. aeruginosa strains showed improved survival compared with survival when paired with a P. aeruginosa reference strain, consistent with adaptation toward coexistence. Together, these findings demonstrate that CF-like environmental conditions and polymicrobial interactions drive selective reprogramming of efflux pumps that promote S. aureus persistence without conferring high-level resistance, highlighting a mechanism of antibiotic tolerance not captured by standard susceptibility testing.
SN - 1098-6596
SN - 0066-4804
ER -